In a meta-analysis of the different insulin sensitizers in individuals with PCOS, thiazolidinediones were superior to metformin in terms of increasing HDL cholesterol, reducing LDL cholesterol, and decreasing fasting plasma glucose and triglycerides. The gene discussed is INS; the disease is polycystic ovary syndrome.